BioFIT 2019 programme is available!

Home » Archives for Valentine Delabie » Page 14

BioFIT 2019 programme is now available

In this brochure, you will find all the information you need about the 8^th edition of the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences.

Download

Continue your tour

Contact

Juliette Vanbastelaere

Event project officer

jvanbastelaere@eurasante.com

+33 9 78 31 61 85

BioFIT 2019 programme is available! Read More »

[Hosted Events] European Diagnostic Clusters Alliance – EDCA

News / Valentine Delabie

December 5^th 2018

10.30 am – 12.30 pm
Lille, France

EDCA invites you to a round table during BioFIT to exchange on the hot topic of the new European In Vitro Diagnostic Regulation.

About EDCA:

European Diagnostic Clusters Alliance – EDCA is the first European network serving the competitiveness of the medical diagnostic industry. It federates 8 European clusters and counts 350 companies.

The purpose of EDCA is:

To promote competitiveness of European industry in the area of medical diagnosis. The association will enhance the synergies between academic research, clinical research, health authorities and diagnostic companies;
To ease the growth of European SMEs in medical diagnostic;
To promote the development of diagnostic clusters and competitiveness clusters in Europe;
To promote cooperation between diagnostic clusters (inter-cluster) in order to help build European collaborative projects.

EDCA members:

BioTurku (Finland)
BioWales (United Kingdom)
BioWin (Belgium)
Eurobiomed (France)
Heath Capital (Germany)
Medicen (France)
The Oxford AHSN (United Kingdom)
Uppsala Bio (Sweden)

[Hosted Events] European Diagnostic Clusters Alliance – EDCA Read More »

We are very honoured to count Ferring among the Sponsors of BioFIT 2018

News / Valentine Delabie

Many thanks to Ferring for joining BioFIT 2018 as a Silver Sponsor

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth.

Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT, VIB, Ferring Pharmaceuticals and Sanofi to have the opportunity to:

Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

We are very honoured to count Ferring among the Sponsors of BioFIT 2018 Read More »

Meet the Pharma at BioFIT 2018!

News / Valentine Delabie

Discover who will be attending:

ALMIRALL S.A.
BAYER HEALTHCARE
BOEHRINGER INGELHEIM
EA PHARMA CO., LTD.
ELANCO
FERRING PHARMACEUTICALS
GSK – GLAXOSMITHKLINE
IPSEN INNOVATION
JOHNSON & JOHNSON
JT PHARMA
LEO PHARMA A/S
LFB
LILLY
MARUHO CO.
MERCK
MOCHIDA PHARMACEUTICAL CO., LTD.
MSD
NOVO NORDISK
PFIZER
ROCHE
SANOFI
SERVIER
SUMITOMO DAINIPPON PHARMA
VIRBAC
ZOETIS

See more participants

Meet the Pharma at BioFIT 2018! Read More »

[Hosted events] Innovation @ Boehringer Ingelheim – PARTNERING DAY

News / Valentine Delabie

PARTNERING DAY
December 3^rd, 2018

Fostering Innovation

Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s global pharmaceutical organisation, we know how important it is to nurture and develop emerging science and technology.
Our track record of bringing breakthrough medicines to patients starts with new ideas and new science, and collaborations with external partners play a key role in helping us deliver an innovation-led portfolio. Join us at our partnering day to explore how we can develop the next generation of medicines together.
For more information on our partnering interests please visit: www.boehringer-ingelheim.com/partnering/interests.

Meet our research and partnering team

Research and partnering teams will be available throughtout the day for networking.

Discover the whole programme

Register to attend and apply for a one-to-one meeting

Register to attend the event and, if interested, apply for a one-to-one meeting to discuss potential opportunities for partnering with our team.

Deadline: 1^st November

[Hosted events] Innovation @ Boehringer Ingelheim – PARTNERING DAY Read More »

[Hosted events] EGID Symposium

News / Valentine Delabie

The European Genomic Institute for Diabetes (EGID) will host its 5^th international symposium: the gut, incretins and diabetes, from December 4^th, 2018, Lille.

This biennial event brings an international focus to our work by the joining of the IDEA Summit and the EGID symposium.
The committee and speakers are world leaders in their fields and will present the latest scientific advances in diabetes and related disorders.
This symposium provides an opportunity for young researchers to present their work via poster presentation and to win the “Best Poster Award” of up to 1000 euros.

Conference Programme:

8.30 – 9.15 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION

9.15 – 9.30 AM
INTRODUCTION AND WELCOMING

9.30 – 10.15 AM
INSIGHTS FROM BARIATRIC SURGERY

RACHEL BATTERHAM
Professor of Obesity, Diabetes and Endocrinology – NIHR Research Professor, Head of UCLH Obesity & Bariatric Services, Head of Center for Obesity Research, Department of Medicine, Rayne Building, University College London

10.15 – 11.00 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE INSIDE OF THE SYSTEM

ROY TAYLOR
Professor of Medicine and Metabolism, Magnetic Resonance Centre, Campus for Ageing and Vitality, Newcastle upon Tyne

11.00 – 11.30 AM
EGID POSTER SESSION

11.30 AM – 1.00 PM
BIOFIT PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?

1:00 PM – 2.30 PM
LUNCH

2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE

NIKOLAUS MARX
Director of the Medical Cardiology Clinic – Cardiology, pneumonology, angiology, internal intensive care Aachen University Hospital

3.15 – 4.00 PM
GUT-BRAIN GLUCOSE SIGNALING IN THE CONTROL OF ENERGY HOMEOSTASIS

GILLES MITHIEUX
Research Director – CNRS Director of U1213, Nutrition, Diabetes and the Brain

4.00 – 4.30 PM
NETWORKING BREAK

4.30 – 5.15 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN

AIMO KANNT
Head of Department, General Metabolism & Obesity, Sanofi

5.15 – 5.30 PM
BEST PAPER AWARD

5.30 – 6.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL

Partners:

[Hosted events] EGID Symposium Read More »

[Hosted events] WBC Club: Would-be CEO networking lunch

News / Valentine Delabie

BioFIT and the WBC Incubator are pleased to announce that they will be putting together a special edition of WBC Club during BioFIT 2018 in Lille. This session, called «Would-be CEO Networking Lunch», will be held on the second day of BioFIT (5^th December).

As talented CEOs are so much sought-after by so many stakeholders of the biotech industry, to both launch and drive new companies to success, this special WBC Club session will bring together representatives of emerging start-ups, technology transfer offices, incubators and investing networks as well as CEOs and would-be CEOs to address this crucial issue.

Since 2010, WBC Incubator has validated close to 100 biotech professionals in Belgium for their ability to match and work with scientific founders and entrepreneurs with the collective aim to build together more exciting business plans, stronger investment propositions and faster business development programmes. In Belgium, biotech CEOs and Would-be CEOs meet regularly to discuss business opportunities during so-called WBC Club events.

The «Would-be CEO Networking Lunch» is organised to present the WBC incubation model to BioFIT participants. Please also note that Would-be CEOs will be identified using the BioFIT partnering platform.

Any bioentrepreneur looking for a project to get involved in is welcome to join BioFIT and particularly this would-be CEOs networking lunch. Any incubator or tech transfer entity looking for an entrepreneur to lead their start-up launch projects is also welcome to join.

[Hosted events] WBC Club: Would-be CEO networking lunch Read More »

5 days left to save money!

News / Valentine Delabie

In 5 days, it will be too late to enjoy the Early Bird offer!

If you are interested in attending BioFIT on 4^th and 5^th December 2018 in Lille, France, enjoy the Early Bird offer before it ends, after this Saturday it will be too late!

5 days left to save money! Read More »